Patients and caregivers can use Folia to track any condition or an undiagnosed disorder, however we work closely with two communities.
Folia was first founded in 2017 in partnership with the Cystic Fibrosis community. Cystic Fibrosis is a progressive, genetic disease that affects the respiratory and digestive system in 30,000 Americans.
After completing our pilot, Folia chose Primary Immunodeficiency as its second condition of focus. Primary Immunodeficiency includes over 350 subtypes.